Join the club for FREE to access the whole archive and other member benefits.

Nuchido TIME+ reports results of 28-day clinical trial

Increases in NAD+, NAMPT enzyme and SIRT1 levels. Over 1 year reduction in biological age measured by GlycanAge.

06-Apr-2023

Key points from article :

Nuchido ran a gold-standard randomised, double-blinded, placebo-controlled crossover clinical trial.

Participants were male and female, aged 20-80 years old (number of participants not stated).

Biomarkers were measured at 7 and 28 days.

NAD+ levels significantly increase after only 7 days of supplementation. Increase of ~18 ng/ml after 28 days.


NAMPT enzyme levels increased after 28 days of supplementation.

SIRT1 increased significantly.

Reduction in inflammatory factors (cytokines IL-2, IL-5, IL-23).

Found to decrease glycated serum protein.

Nuchido TIME+ did not have any significant effect on biomarkers of safety.

Biological age  reduced by an average of 1.26 years after 28 days of supplementation (using GlycanAge test).

Planning to have results published in a peer-reviewed journal.

Mentioned in this article:

Click on resource name for more details.

GlycanAge

Club discount available - click here

Glycan-based test to determine your biological age

Nuchido

Club discount available - click here

Nuchido TIME+ is a powerful NAD+ supplement using a proprietary formula

Topics mentioned on this page:
NAD+, Supplements
Nuchido TIME+ reports results of 28-day clinical trial